Windtree Therapeutics, Inc. (WINT)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Jul 30, 2026
Windtree Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -39.99 | -1.79 | -20.29 | -39.21 | -67.64 | -32.57 |
Depreciation & Amortization | 0.41 | 0.08 | 0.08 | 0.13 | 0.19 | 0.17 |
Other Amortization | 0.19 | 0.1 | - | - | - | - |
Loss (Gain) From Sale of Assets | - | - | 0.01 | 0.02 | - | - |
Asset Writedown & Restructuring Costs | 24.67 | 8.54 | 3.06 | 19.84 | 45.02 | - |
Stock-Based Compensation | 0.14 | 0.64 | 1.28 | 3.09 | 7.73 | 5.68 |
Other Operating Activities | -1.21 | -24.34 | 0.41 | -1.55 | -8.91 | 2.73 |
Change in Accounts Payable | -0.4 | 1.07 | 0.56 | -0.44 | -0.47 | -0.55 |
Change in Other Net Operating Assets | 1.08 | 0.3 | 1.46 | -1.33 | 0.41 | -0.78 |
Operating Cash Flow | -15.12 | -15.4 | -13.44 | -19.45 | -23.66 | -25.32 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Capital Expenditures | - | -0.01 | -0.02 | -0.01 | -0.28 | -0.29 |
Sale of Property, Plant & Equipment | - | - | - | 0.21 | - | - |
Investing Cash Flow | -5.97 | -0.01 | -0.02 | 0.2 | -0.28 | -0.29 |
Short-Term Debt Issued | - | 1.86 | - | - | - | 0.55 |
Total Debt Issued | 4.8 | 1.86 | - | - | - | 0.55 |
Short-Term Debt Repaid | - | -0.61 | -0.8 | -1.17 | -3.87 | -0.55 |
Long-Term Debt Repaid | - | -0.2 | - | - | - | -3.23 |
Total Debt Repaid | -3.32 | -0.81 | -0.8 | -1.17 | -3.87 | -3.78 |
Net Debt Issued (Repaid) | 1.49 | 1.06 | -0.8 | -1.17 | -3.87 | -3.23 |
Issuance of Common Stock | 20.82 | 14.28 | 12.39 | 4.25 | 32.23 | 20.39 |
Preferred Dividends Paid | -0.4 | -0.66 | - | - | - | - |
Dividends Paid | -0.4 | -0.66 | - | - | - | - |
Other Financing Activities | - | -0.07 | - | - | 1 | 2.8 |
Financing Cash Flow | 19 | 12.73 | 11.6 | 3.08 | 29.36 | 19.96 |
Net Cash Flow | -2.1 | -2.68 | -1.86 | -16.18 | 5.42 | -5.65 |
Free Cash Flow | -15.12 | -15.41 | -13.45 | -19.47 | -23.94 | -25.61 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -1.83 | -293.14 | - | - | - | - |
Levered Free Cash Flow | -23.64 | -12.85 | -7.85 | -12.62 | -13.42 | -14.74 |
Unlevered Free Cash Flow | -9.53 | -12.8 | -7.82 | -12.59 | -13.35 | -14.66 |
Change in Working Capital | 0.68 | 1.37 | 2.02 | -1.78 | -0.06 | -1.33 |